Novartis (NVS) calls active on Alcon (ALC) eye care spin-off
Tweet
Share
E-mail
Get Alerts NVS Hot Sheet
Join SI Premium – FREE
Novartis (NYSE: NVS) call put ratio 5.1 calls to 1 put after completes spin-off of the Alcon (ALC) eye care device business through a dividend in kind distribution to holders of Novartis shares and ADR's.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novartis MS drug remibrutinib meets Phase III trial goals
- lululemon athletica (LULU) call put ratio 1.2 calls to 1 put into quarter results
- Docusign Inc. (DOCU) call put ratio 1 call to 1.2 puts into quarter results
Create E-mail Alert Related Categories
OptionsRelated Entities
Alcon Acquired by NovartisSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
